{"id":"https://openalex.org/W2334593615","doi":"https://doi.org/10.1097/olq.0000000000000152","title":"Periodic Presumptive Treatment for Women With Prevalent Vaginal Infections","display_name":"Periodic Presumptive Treatment for Women With Prevalent Vaginal Infections","publication_year":2014,"publication_date":"2014-06-12","ids":{"openalex":"https://openalex.org/W2334593615","doi":"https://doi.org/10.1097/olq.0000000000000152","mag":"2334593615","pmid":"https://pubmed.ncbi.nlm.nih.gov/24922105","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4425269"},"language":"en","primary_location":{"id":"doi:10.1097/olq.0000000000000152","doi":"https://doi.org/10.1097/olq.0000000000000152","is_oa":false,"landing_page_url":"https://doi.org/10.1097/olq.0000000000000152","pdf_url":null,"source":{"id":"https://openalex.org/S170339494","display_name":"Sexually Transmitted Diseases","issn_l":"0148-5717","issn":["0148-5717","1537-4521"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually Transmitted Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4425269","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014610004","display_name":"Vernon Mochache","orcid":"https://orcid.org/0000-0001-7413-0252","observed_orcids":["https://orcid.org/0000-0001-7413-0252"]},"institutions":[{"id":"https://openalex.org/I12859529","display_name":"University of Nairobi","ror":"https://ror.org/02y9nww90","country_code":"KE","type":"education","lineage":["https://openalex.org/I12859529"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210086618","display_name":"International Centre for Reproductive Health","ror":"https://ror.org/003093432","country_code":"MZ","type":"facility","lineage":["https://openalex.org/I4210086618"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]},{"id":"https://openalex.org/I874236823","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I874236823"]}],"countries":["KE","MZ","US"],"is_corresponding":false,"raw_author_name":"Vernon Mochache","raw_affiliation_strings":["Department of Epidemiology, University of Washington, Seattle, WA Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA Department of Global Health, University of Washington, Seattle, WA jbalkus@fhcrc.org","Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","Department of Epidemiology, University of Washington, Seattle, WA","Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","Mombasa, Kenya","Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of Washington, Seattle, WA Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA Department of Global Health, University of Washington, Seattle, WA jbalkus@fhcrc.org","institution_ids":["https://openalex.org/I12859529","https://openalex.org/I201448701","https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","institution_ids":["https://openalex.org/I874236823"]},{"raw_affiliation_string":"Department of Epidemiology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","institution_ids":["https://openalex.org/I4210086618"]},{"raw_affiliation_string":"Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","institution_ids":["https://openalex.org/I12859529"]},{"raw_affiliation_string":"Mombasa, Kenya","institution_ids":[]},{"raw_affiliation_string":"Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026703630","display_name":"Raymond Scott McClelland","orcid":"https://orcid.org/0000-0003-2574-4201","observed_orcids":["https://orcid.org/0000-0003-2574-4201"]},"institutions":[{"id":"https://openalex.org/I12859529","display_name":"University of Nairobi","ror":"https://ror.org/02y9nww90","country_code":"KE","type":"education","lineage":["https://openalex.org/I12859529"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210086618","display_name":"International Centre for Reproductive Health","ror":"https://ror.org/003093432","country_code":"MZ","type":"facility","lineage":["https://openalex.org/I4210086618"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]},{"id":"https://openalex.org/I874236823","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I874236823"]}],"countries":["KE","MZ","US"],"is_corresponding":false,"raw_author_name":"Raymond Scott McClelland","raw_affiliation_strings":["Department of Epidemiology, University of Washington, Seattle, WA","Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA","Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","Mombasa, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","institution_ids":["https://openalex.org/I12859529"]},{"raw_affiliation_string":"Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","institution_ids":["https://openalex.org/I874236823"]},{"raw_affiliation_string":"Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","institution_ids":["https://openalex.org/I4210086618"]},{"raw_affiliation_string":"Mombasa, Kenya","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033049388","display_name":"Jennifer E. Balkus","orcid":"https://orcid.org/0000-0002-9950-2523","observed_orcids":["https://orcid.org/0000-0002-9950-2523","https://orcid.org/0000-0003-2015-4739"]},"institutions":[{"id":"https://openalex.org/I12859529","display_name":"University of Nairobi","ror":"https://ror.org/02y9nww90","country_code":"KE","type":"education","lineage":["https://openalex.org/I12859529"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210086618","display_name":"International Centre for Reproductive Health","ror":"https://ror.org/003093432","country_code":"MZ","type":"facility","lineage":["https://openalex.org/I4210086618"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]},{"id":"https://openalex.org/I874236823","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I874236823"]}],"countries":["KE","MZ","US"],"is_corresponding":false,"raw_author_name":"Jennifer E. Balkus","raw_affiliation_strings":["Department of Epidemiology, University of Washington, Seattle, WA","Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA","Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","Mombasa, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Department of Global Health, University of Washington, Seattle, WA [email\u00a0protected]","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya","institution_ids":["https://openalex.org/I12859529"]},{"raw_affiliation_string":"Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Conflicts of interest and sources of funding: Dr R. Scott McClelland has been a consultant and received donated study product from Embil Pharmaceuticals. He has also received research funding from Hologic/GenProbe. He received support for the original trial from the National Institutes of Health Research Grant K23-AI52480. Dr Vernon Mochache was a scholar in the University of Washington, International AIDS Research and Training Program supported by the Fogarty International Center, National Institutes of Health Research Grant D43 TW000007. Infrastructure and logistical support for the Mombasa Field Site was received from the University of Washington and Fred Hutchinson Cancer Research Center\u2019s Center for AIDS Research (Grant No. P30-AI27757)","institution_ids":["https://openalex.org/I874236823"]},{"raw_affiliation_string":"Dr. Vernon Mochache\u2019s current affiliation: International Centre for Reproductive Health","institution_ids":["https://openalex.org/I4210086618"]},{"raw_affiliation_string":"Mombasa, Kenya","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.22738293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"41","issue":"7","first_page":"453","last_page":"453"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bacterial-vaginosis","display_name":"bacterial vaginosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/vaginal-candidiasis","display_name":"vaginal candidiasis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/trichomonas-vaginalis","display_name":"Trichomonas vaginalis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":0.8759999871253967},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/female-sex-workers","display_name":"female sex workers","score":0.8270000219345093},{"id":"https://openalex.org/keywords/recurrent-infections","display_name":"recurrent infections","score":0.3630000054836273},{"id":"https://openalex.org/keywords/reinfection-prevention","display_name":"reinfection prevention","score":0.6759999990463257},{"id":"https://openalex.org/keywords/effect-modification","display_name":"effect modification","score":0.5889999866485596},{"id":"https://openalex.org/keywords/sexually-transmitted-infections","display_name":"sexually transmitted infections","score":0.6050000190734863},{"id":"https://openalex.org/keywords/reproductive-outcomes","display_name":"reproductive outcomes","score":0.546999990940094},{"id":"https://openalex.org/keywords/kenya","display_name":"Kenya","score":0.43299999833106995},{"id":"https://openalex.org/keywords/nugent-score","display_name":"Nugent score","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9197613000869751},{"id":"https://openalex.org/C2779952448","wikidata":"https://www.wikidata.org/wiki/Q804521","display_name":"Bacterial vaginosis","level":2,"score":0.8698477745056152},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5953976511955261},{"id":"https://openalex.org/C2781114625","wikidata":"https://www.wikidata.org/wiki/Q132595","display_name":"Trichomonas vaginalis","level":2,"score":0.5737588405609131},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4964807629585266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49549829959869385},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4858057498931885},{"id":"https://openalex.org/C2777700855","wikidata":"https://www.wikidata.org/wiki/Q18211693","display_name":"Vaginal disease","level":3,"score":0.4664774537086487},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45328760147094727},{"id":"https://openalex.org/C2777023796","wikidata":"https://www.wikidata.org/wiki/Q745865","display_name":"Trichomoniasis","level":2,"score":0.4261070489883423},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.41884875297546387},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4118034839630127},{"id":"https://openalex.org/C131872663","wikidata":"https://www.wikidata.org/wiki/Q5284418","display_name":"Obstetrics","level":1,"score":0.3777749240398407},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.37749966979026794},{"id":"https://openalex.org/C2777744392","wikidata":"https://www.wikidata.org/wiki/Q5880","display_name":"Vagina","level":2,"score":0.3395193815231323},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1699385941028595},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002181","descriptor_name":"Candidiasis, Vulvovaginal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002181","descriptor_name":"Candidiasis, Vulvovaginal","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007630","descriptor_name":"Kenya","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014247","descriptor_name":"Trichomonas Vaginitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014247","descriptor_name":"Trichomonas Vaginitis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016585","descriptor_name":"Vaginosis, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016585","descriptor_name":"Vaginosis, Bacterial","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018890","descriptor_name":"Chemoprevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D060386","descriptor_name":"Sex Workers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/olq.0000000000000152","doi":"https://doi.org/10.1097/olq.0000000000000152","is_oa":false,"landing_page_url":"https://doi.org/10.1097/olq.0000000000000152","pdf_url":null,"source":{"id":"https://openalex.org/S170339494","display_name":"Sexually Transmitted Diseases","issn_l":"0148-5717","issn":["0148-5717","1537-4521"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually Transmitted Diseases","raw_type":"journal-article"},{"id":"pmid:24922105","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24922105","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually transmitted diseases","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:4425269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4425269","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Sex Transm Dis","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4425269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4425269","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Sex Transm Dis","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3865545756","display_name":"AIDS International Training and Research Program","funder_award_id":"D43TW000007","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G6107019537","display_name":"REDUCING VAGINAL INFECTIONS IN WOMEN AT RISK FOR HIV-1","funder_award_id":"K23AI052480","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000868680","display_name":"University of Washington/Fred Hutch Center for AIDS Research","funder_award_id":"P30AI027757","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1978444441","https://openalex.org/W2001360077","https://openalex.org/W2012356205","https://openalex.org/W2044148516","https://openalex.org/W2061198932","https://openalex.org/W2124065962","https://openalex.org/W2144655568","https://openalex.org/W2145398766","https://openalex.org/W2152457726"],"related_works":["https://openalex.org/W2252720940","https://openalex.org/W2565543322","https://openalex.org/W2098200653","https://openalex.org/W2417041602","https://openalex.org/W2316453663","https://openalex.org/W2970791188","https://openalex.org/W2900913649","https://openalex.org/W7098521998","https://openalex.org/W2968187570","https://openalex.org/W2903509631"],"abstract_inverted_index":{"To":[0],"the":[1,69,89,104,135,138,160,241,250,267,274,294,301,332,358,379,387,448,489],"Editor:":[2],"Bacterial":[3,253],"vaginosis":[4,254],"(BV),":[5],"vulvovaginal":[6],"candidiasis":[7],"(VVC)":[8],"and":[9,34,56,94,192,208,225,437,473,532,542,556],"Trichomonas":[10],"vaginalis":[11],"(TV)":[12],"are":[13,126],"common":[14],"vaginal":[15,124,215,449,486,508],"infections":[16,125,216,487],"associated":[17],"with":[18,122,146,173,236,258,331,340,347,366,370,407,484],"adverse":[19],"reproductive":[20],"health":[21],"outcomes,":[22,441],"including":[23,466],"sexually":[24],"transmitted":[25],"infections.1\u20136":[26],"Their":[27],"treatment":[28,38],"is":[29,488],"hindered":[30],"by":[31,108,167,184,316,416,458],"frequent":[32],"recurrences":[33],"reinfection.":[35],"Periodic":[36],"presumptive":[37],"(PPT)":[39],"has":[40],"been":[41],"evaluated":[42,181],"as":[43,427],"an":[44,189],"alternative":[45],"approach":[46,492],"that":[47,137,385,433,479],"involves":[48],"providing":[49],"antimicrobials":[50],"to":[51,54,67,128,133,158,361,382,462,482,493,506],"asymptomatic":[52],"women":[53,121,198,406,483],"treat":[55,362,383],"potentially":[57],"prevent":[58],"these":[59],"infections.7,8":[60],"We":[61,152,180],"previously":[62],"conducted":[63],"a":[64,147,177,237,259,285,341,355,371,408,430,443],"randomized":[65,431],"trial":[66,432],"assess":[68,159],"effect":[70,140,162,182,314],"of":[71,91,106,233,247,313,429,447,452,515,518,528,535,540,546,568,572],"monthly":[72],"oral":[73],"PPT":[74,139,402,481],"(2":[75],"g":[76],"metronidazole":[77],"plus":[78],"150":[79],"mg":[80],"fluconazole)":[81],"versus":[82,244,270,297,334],"placebo":[83,251,275,302,335],"administered":[84],"for":[85,202,421],"12":[86],"months":[87],"on":[88,163],"incidence":[90,105,165,255,289],"BV,":[92,221],"VVC,":[93,224],"TV":[95],"among":[96,144,256,338,368],"Kenyan":[97],"female":[98,463],"sex":[99,464],"workers.7":[100],"The":[101,326],"intervention":[102,242,268,295,333,388],"reduced":[103],"BV":[107,164,174,288,329,396,418,495],"Nugent\u2019s":[109],"score":[110],"(hazard":[111],"ratio":[112,194,321],"[HR],":[113],"0.55;":[114,278],"95%":[115,279,306],"confidence":[116],"interval":[117],"[CI],":[118],"0.49\u20130.63).":[119],"Because":[120],"prevalent":[123,148,409,485],"likely":[127],"experience":[129],"recurrences/reinfection,8,9":[130],"we":[131],"sought":[132],"test":[134],"hypothesis":[136],"would":[141],"be":[142,399,456,500],"greater":[143,337],"participants":[145,235,257,339,353],"infection":[149,169,186,239,261,318,343],"at":[150,203,217],"enrollment.":[151],"used":[153],"Andersen-Gill":[154],"proportional":[155],"hazards":[156],"models":[157],"intervention\u2019s":[161],"stratified":[166,415],"baseline":[168,185,238,260,286,317,342,356,372,417],"status.":[170,419],"Each":[171],"visit":[172,207],"was":[175,262,290,310,336,363,389],"considered":[176],"\u201cnew\u201d":[178],"event.":[179],"modification":[183,315],"status":[187,319],"using":[188],"interaction":[190],"term":[191],"likelihood":[193],"test.":[195],"Among":[196,282],"310":[197],"enrolled,":[199],"302":[200],"returned":[201],"least":[204],"1":[205,212],"follow-up":[206],"137":[209],"(45%)":[210],"had":[211,434],"or":[213],"more":[214,395,444],"enrollment:":[218],"105":[219],"(77%)":[220],"32":[222],"(23%)":[223],"6":[226],"(4%)":[227],"TV.":[228],"There":[229,309],"were":[230,403,412,425],"62":[231],"(41%)":[232],"151":[234,248],"in":[240,249,266,273,293,300,328,378,392,468,502],"arm":[243,269,276,296,303],"75":[245],"(50%)":[246],"arm.":[252],"294/100":[263],"person-years":[264],"(py)":[265],"522/100":[271],"py":[272,292,299],"(HR,":[277,304],"CI,":[280,307],"0.41\u20130.76).":[281],"those":[283,348,369],"without":[284,349,354],"infection,":[287,357],"141/100":[291],"202/100":[298],"0.71;":[305],"0.47\u20131.09).":[308],"no":[311],"evidence":[312],"(likelihood":[320],"test:":[322],"P":[323],"=":[324],"0.11).":[325],"reduction":[327],"episodes":[330,397],"(228/100":[344],"py)":[345],"compared":[346,365],"(61/100":[350],"py).":[351],"For":[352],"number":[359,380],"needed":[360,381],"16.7":[364],"4.4":[367],"infection.":[373,410],"This":[374],"approximately":[375],"4-fold":[376],"difference":[377],"suggests":[384],"although":[386],"similarly":[390],"effective":[391],"both":[393],"subgroups,":[394],"could":[398],"averted":[400],"if":[401],"targeted":[404],"toward":[405],"Findings":[411],"similar":[413],"when":[414],"Data":[420],"this":[422],"secondary":[423],"analysis":[424],"collected":[426],"part":[428],"high":[435],"retention":[436],"regularly":[438],"measured":[439],"biological":[440],"enabling":[442],"precise":[445],"assessment":[446],"environment.":[450],"Generalizability":[451],"our":[453],"findings":[454,477],"may":[455],"limited":[457],"behavioral":[459],"characteristics":[460],"unique":[461],"workers,":[465],"differences":[467],"sexual":[469],"activity,":[470],"condom":[471],"use,":[472],"intravaginal":[474],"practices.":[475],"Our":[476],"suggest":[478],"targeting":[480],"most":[490],"efficient":[491],"reducing":[494],"incidence.":[496],"These":[497],"results":[498],"will":[499],"useful":[501],"designing":[503],"future":[504],"trials":[505],"improve":[507],"health.":[509],"Vernon":[510],"Mochache,":[511],"MBChB,":[512],"MPH":[513,526,554],"Department":[514,567],"Epidemiology":[516,529],"University":[517,534,545,571],"Washington":[519,536,573],"Seattle,":[520,537,565,574],"WA":[521,538,566,575],"Raymond":[522],"Scott":[523],"McClelland,":[524],"MD,":[525],"Departments":[527],"Global":[530,569],"Health,":[531],"Medicine":[533],"Institute":[539],"Tropical":[541],"Infectious":[543,557],"Diseases":[544],"Nairobi":[547],"Nairobi,":[548],"Kenya":[549],"Jennifer":[550],"E.":[551],"Balkus,":[552],"PhD,":[553],"Vaccine":[555],"Disease":[558],"Division":[559],"Fred":[560],"Hutchison":[561],"Cancer":[562],"Research":[563],"Center":[564],"Health":[570],"[email":[576],"protected]":[577]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}